A. Aartsma-rus, A. Janson, W. Kaman, M. Bremmer-bout, J. Den-dunnen et al., Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients, Human Molecular Genetics, vol.12, issue.8, pp.907-914, 2003.
DOI : 10.1093/hmg/ddg100

J. Alter, F. Lou, A. Rabinowitz, H. Yin, J. Rosenfeld et al., Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology, Nature Medicine, vol.306, issue.2, pp.175-177, 2006.
DOI : 10.1038/nm1345

M. Bremmer-bout, A. Aartsma-rus, E. De-meijer, W. Kaman, A. Janson et al., Targeted Exon Skipping in Transgenic hDMD Mice: A Model for Direct Preclinical Screening of Human-Specific Antisense Oligonucleotides, Molecular Therapy, vol.10, issue.2, pp.232-240, 2004.
DOI : 10.1016/j.ymthe.2004.05.031

D. Cacchiarelli, MicroRNAs Involved in Molecular Circuitries Relevant for the Duchenne Muscular Dystrophy Pathogenesis Are Controlled by the Dystrophin/nNOS Pathway, Cell Metabolism, vol.12, issue.4, pp.341-351, 2010.
DOI : 10.1016/j.cmet.2010.07.008

J. Chen, E. Mandel, J. Thomson, Q. Wu, T. Callis et al., The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation, Nature Genetics, vol.132, issue.2, pp.228-233, 2006.
DOI : 10.1038/ng1725

P. Daubas, C. Crist, L. Bajard, F. Relaix, E. Pecnard et al., The regulatory mechanisms that underlie inappropriate transcription of the myogenic determination gene Myf5 in the central nervous system, Developmental Biology, vol.327, issue.1, pp.71-82, 2009.
DOI : 10.1016/j.ydbio.2008.11.031

D. Angelis, F. Sthandier, O. Berarducci, B. Toso, S. Galluzzi et al., Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in ??48-50 DMD cells, Proceedings of the National Academy of Sciences, vol.99, issue.14, pp.9456-9461, 2002.
DOI : 10.1073/pnas.142302299

M. Denti, A. Rosa, O. Sthandier, D. Angelis, F. Bozzoni et al., A new vector, based on the PolII promoter for the U1 snRNA gene, for the expression of siRNAs in mammalian cells, Molecular Therapy, vol.10, issue.1, pp.191-199, 2004.
DOI : 10.1016/j.ymthe.2004.04.008

M. Denti, Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model, Proceedings of the National Academy of Sciences, vol.103, issue.10, pp.3758-3763, 2006.
DOI : 10.1073/pnas.0508917103

M. Denti, T. Incitti, O. Sthandier, C. Nicoletti, D. Angelis et al., Long-Term Benefit of Adeno-Associated Virus/Antisense-Mediated Exon Skipping in Dystrophic Mice, Human Gene Therapy, vol.19, issue.6, pp.601-608, 2008.
DOI : 10.1089/hum.2008.012

M. Dunckley, M. Manoharan, P. Villiet, I. Eperon, and G. Dickson, Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides, Human Molecular Genetics, vol.7, issue.7, pp.1083-1090, 1998.
DOI : 10.1093/hmg/7.7.1083

I. Eisenberg, Distinctive patterns of microRNA expression in primary muscular disorders, Proceedings of the National Academy of Sciences, vol.104, issue.43, pp.17016-17021, 2007.
DOI : 10.1073/pnas.0708115104

S. Fletcher, K. Honeyman, A. Fall, P. Harding, R. Johnsen et al., Dystrophin expression in themdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide, The Journal of Gene Medicine, vol.6, issue.2, pp.207-216, 2006.
DOI : 10.1002/jgm.838

B. Gentner, G. Schira, A. Giustacchini, M. Amendola, B. Brown et al., Stable knockdown of microRNA in vivo by lentiviral vectors, Nature Methods, vol.6, issue.1, pp.63-66, 2009.
DOI : 10.1016/j.cell.2005.06.036

A. Goyenvalle, A. Vulin, F. Fougerousse, F. Leturcq, J. Kaplan et al., Rescue of Dystrophic Muscle Through U7 snRNA-Mediated Exon Skipping, Science, vol.306, issue.5702, pp.1796-1799, 2004.
DOI : 10.1126/science.1104297

S. Greco, Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia, The FASEB Journal, vol.23, issue.10, pp.3335-3346, 2009.
DOI : 10.1096/fj.08-128579

T. Incitti, D. Angelis, F. Cazzella, V. Sthandier, O. Pinnarò et al., Exon skipping and Duchenne muscular dystrophy miR-31 targets dystrophin D. Cacchiarelli et al EMBO reports EUROPEAN MOLECULAR BIOLOGY ORGANIZATION scientific report therapy: selection of the most active U1 snRNA-antisense able to induce dystrophin exon 51 skipping, Mol Ther, vol.12, issue.18, pp.1675-1682, 2010.

I. Naguibneva, M. Ameyar-zazoua, A. Polesskaya, S. Ait-si-ali, R. Groisman et al., The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation, Nature Cell Biology, vol.123, issue.3, pp.278-284, 2006.
DOI : 10.1038/ncb1373

URL : https://hal.archives-ouvertes.fr/inserm-00091598

J. Pena, miRNA in situ hybridization in formaldehyde and EDC???fixed tissues, Nature Methods, vol.13, issue.2, pp.139-141, 2009.
DOI : 10.1261/rna.480407

T. Rando and H. Blau, Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy, The Journal of Cell Biology, vol.125, issue.6, pp.1275-1287, 1994.
DOI : 10.1083/jcb.125.6.1275

R. Taulli, F. Bersani, V. Foglizzo, A. Linari, E. Vigna et al., The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation, Journal of Clinical Investigation, vol.119, pp.2366-2378, 2009.
DOI : 10.1172/JCI38075DS1

S. Valastyan and R. Weinberg, miR-31: A crucial overseer of tumor metastasis and other emerging roles, Cell Cycle, vol.9, issue.11, pp.2124-2129, 2010.
DOI : 10.4161/cc.9.11.11843

J. Van-deutekom, Local Dystrophin Restoration with Antisense Oligonucleotide PRO051, New England Journal of Medicine, vol.357, issue.26, pp.2677-2686, 2007.
DOI : 10.1056/NEJMoa073108

E. Van-rooij, W. Marshall, and E. Olson, Toward MicroRNA-Based Therapeutics for Heart Disease: The Sense in Antisense, Circulation Research, vol.103, issue.9, pp.919-928, 2008.
DOI : 10.1161/CIRCRESAHA.108.183426